We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NULG icon
6476
Nuveen ESG Large-Cap Growth ETF
NULG
$2.67B
-400
Closed -$14K
OBE
6477
Obsidian Energy
OBE
$678M
-316,454
Closed -$53K
OGEN icon
6478
Oragenics
OGEN
$2.21M
0
ONEV icon
6479
State Street SPDR Russell 1000 Low Volatility Focus ETF
ONEV
$305M
-135
Closed -$8K
OPHC icon
6480
OptimumBank Holdings
OPHC
$86.5M
$0 ﹤0.01%
8
-3
-27% -$7
OPTT icon
6481
Ocean Power Technologies
OPTT
$43.5M
$0 ﹤0.01%
111
-53
-32% -$26
OTLK icon
6482
Outlook Therapeutics
OTLK
$194M
-42
Closed -$1K
PALI icon
6483
Palisade Bio
PALI
$341M
0
PETZ icon
6484
TDH Holdings
PETZ
$12.2M
0
PHIO icon
6485
Phio Pharmaceuticals
PHIO
$12M
-1
Closed
PLX icon
6486
Protalix BioTherapeutics
PLX
$183M
-10
Closed
POLA icon
6487
Polar Power
POLA
$6.15M
0
PPSI
6488
Pioneer Power Solutions
PPSI
$33M
$0 ﹤0.01%
100
PRSO icon
6489
Peraso
PRSO
$9.71M
0
PSET icon
6490
Principal Exchange-Traded Funds Principal Quality ETF
PSET
$28M
-2,907
Closed -$98K
PSTV icon
6491
Plus Therapeutics
PSTV
$25.1M
0
PTEU icon
6492
Pacer Trendpilot European Index ETF
PTEU
$36.9M
-50
Closed -$1K
QDIV icon
6493
Global X S&P 500 Quality Dividend ETF
QDIV
$30.1M
-3,884
Closed -$72K
QRHC icon
6494
Quest Resource Holding
QRHC
$27.8M
$0 ﹤0.01%
+250
New +$331
RAVE icon
6495
RAVE Restaurant Group
RAVE
$44.1M
$0 ﹤0.01%
500
RCMT icon
6496
RCM Technologies
RCMT
$202M
-3
Closed
RELL icon
6497
Richardson Electronics
RELL
$265M
$0 ﹤0.01%
34
-91
-73% -$365
RETL icon
6498
Direxion Daily Retail Bull 3X ETF
RETL
$31.6M
-1,040
Closed -$2K
RETO icon
6499
ReTo Eco-Solutions
RETO
$23.3M
0
RFEM icon
6500
First Trust RiverFront Dynamic Emerging Markets ETF
RFEM
$77.4M
-123
Closed -$6K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.